# Cycle-Dependent Expression of Immune, Morphogenetic, Apoptotic, and Steroid-Related Markers in the Endometrium of Infertile Women: A Pilot Study

**Authors:** Elizabete Brikune, Māra Pilmane, Jana Brikune

PMC · DOI: 10.3390/cimb48030264 · 2026-03-02

## TL;DR

This pilot study explores how immune, morphogenetic, apoptotic, and steroid-related markers in the endometrium of infertile women change across the menstrual cycle.

## Contribution

The study identifies cycle-dependent expression patterns of multiple endometrial markers in infertile women, suggesting altered temporal coordination may affect fertility.

## Key findings

- G-CSF, BMP-2/4, HSP-70, and PTX-3 show cycle-dependent expression patterns.
- Apoptotic activity increases in mid-to-late cycle days.
- Progesterone and estrogen positivity is limited to specific cycle phases.

## Abstract

Infertility affects a substantial proportion of women of reproductive age and is frequently associated with impaired endometrial receptivity. Successful implantation depends on tightly regulated hormonal, immune, apoptotic, and stress-response pathways within the endometrium. This pilot study aimed to evaluate the expression and distribution of granulocyte colony-stimulating factor (G-CSF), bone morphogenetic proteins 2/4 (BMP-2/4), heat shock protein 70 (HSP-70), apoptosis, progesterone, estrogen, and pentraxin-3 (PTX-3) in the endometrium of infertile women across different menstrual cycle days. A descriptive cross-sectional analysis was performed on endometrial tissue samples obtained from six infertile women aged 21–49 years at various menstrual cycle days. Routine histology, immunohistochemistry, TUNEL assay, and chromogenic in situ hybridization were used to assess tissue morphology, protein expression, apoptotic activity, and PTX-3 gene expression. Quantitative evaluation was applied to immunohistochemical markers and apoptosis, while PTX-3 expression was assessed semi-quantitatively. G-CSF expression showed low-to-moderate levels with a relative mid-cycle increase. BMP-2/4 demonstrated the highest overall positivity across most cycle days, with marked inter-sample variability. HSP-70 exhibited pronounced cycle-dependent variability. Apoptotic activity increased toward mid-to-late cycle days. Progesterone and estrogen positivity was heterogeneous and limited to selected cycle days. PTX-3 gene expression was highest during mid-cycle days and decreased toward later phases. No clear association with patient age was observed. Conclusions: The findings indicate distinct and cycle-dependent patterns of immune, morphogenetic, apoptotic, hormonal, and inflammatory markers in the endometrium of infertile women. These results highlight the dynamic nature of endometrial regulation and suggest that altered temporal coordination of these pathways may contribute to impaired endometrial receptivity.

## Linked entities

- **Genes:** CSF3 (colony stimulating factor 3) [NCBI Gene 1440], BMP2 (bone morphogenetic protein 2) [NCBI Gene 650], BMP4 (bone morphogenetic protein 4) [NCBI Gene 652], HSPA1A (heat shock protein family A (Hsp70) member 1A) [NCBI Gene 3303], PTX3 (pentraxin 3) [NCBI Gene 5806]
- **Proteins:** CSF3 (colony stimulating factor 3), BMP2 (bone morphogenetic protein 2), BMP4 (bone morphogenetic protein 4), HSPA1A (heat shock protein family A (Hsp70) member 1A), PTX3 (pentraxin 3)

## Full-text entities

- **Genes:** CSF3R (colony stimulating factor 3 receptor) [NCBI Gene 1441] {aka CD114, GCSFR, SCN7}, DNTT (DNA nucleotidylexotransferase) [NCBI Gene 1791] {aka TDT}, PTX3 (pentraxin 3) [NCBI Gene 5806] {aka TNFAIP5, TSG-14}, ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, PGR (progesterone receptor) [NCBI Gene 5241] {aka NR3C3, PR}, Ptx3 (pentraxin related gene) [NCBI Gene 19288] {aka TSG-14}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, HSPA4 (heat shock protein family A (Hsp70) member 4) [NCBI Gene 3308] {aka APG-2, HEL-S-5a, HS24/P52, HSPH2, RY, hsp70}, BMP2 (bone morphogenetic protein 2) [NCBI Gene 650] {aka BDA2, BMP2A, SSFSC, SSFSC1}, BMP4 (bone morphogenetic protein 4) [NCBI Gene 652] {aka BMP2B, BMP2B1, MCOPS6, OFC11, ZYME}, CSF3 (colony stimulating factor 3) [NCBI Gene 1440] {aka C17orf33, CSF3OS, GCSF}, BMP1 (bone morphogenetic protein 1) [NCBI Gene 649] {aka OI13, PCOLC, PCP, TLD}
- **Diseases:** implantation failure (MESH:D051437), endometrial hyperplasia (MESH:D004714), inflammation (MESH:D007249), progesterone (MESH:C564871), uterine leiomyomas (OMIM:150699), polycystic ovary syndrome (MESH:D011085), endometrial disorders (MESH:D014591), hypoxia (MESH:D000860), preeclampsia (MESH:D011225), abortions (MESH:D000026), Infertility (MESH:D007246), implantation (MESH:D057873), endocrine deficiency (MESH:D004700), ovarian dysfunction (MESH:D010049), myomas (MESH:D009214), miscarriage (MESH:D000022), adenomyosis (MESH:D062788), insufficiency (MESH:D000309), immune abnormalities (MESH:D007154), endometriosis (MESH:D004715), ovulatory dysfunction (MESH:D006331), metrorrhagia (MESH:D008796), injury to (MESH:D014947), tubal obstruction (MESH:D005184)
- **Chemicals:** Steroid (MESH:D013256), Hematoxylin (MESH:D006416), picric acid (MESH:C005858), H&amp;E (MESH:D006371), 17beta-estradiol (MESH:D004958), Paraffin (MESH:D010232), Formalin (MESH:D005557), xylene (MESH:D014992), biotin (MESH:D001710), EDTA (MESH:D004492), Progesterone (MESH:D011374), eosin (MESH:D004801), dUTP (MESH:C027078), ethanol (MESH:D000431), DAB (-), carboxylic acid (MESH:D002264)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13024835/full.md

---
Source: https://tomesphere.com/paper/PMC13024835